Naser F Al-Tannak

6PUBLICATIONS
10CO-AUTHORS
Biologically active moleculesCardiology (incl. cardiovascular diseases)PharmacogenomicsInstrumental methods (excl. immunological and bioassay methods)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 28, 2026
Semi-Synthetic Cannabinoids in Forensic Toxicology and Public Health: Analytical Challenges, Emerging Detection Strategies, and Regulatory Implications.

|Jul 28, 2026
Validated LC-MS/MS Assays for Novel Triazolyl-Oxazolidinones with Anticonvulsant Activities and Their Potential Applications in Stability and Pharmacokinetic Studies.

|Jun 26, 2026
Assessment and Density Functional Theory of Bioactive Compounds of Curcuma longa L. Root Responsible for Its Cardio-Protective and Anti-Cancer Activities.

|Jan 28, 2026
Stability-Indicating Assay of Novel 5-(Hydroxamic acid)methyl Oxazolidinones with 5-Lipooxygenase Inhibitory Activity.

Hessa M Al-Mutairi, Oludotun A Phillips, Naser F Al-Tannak

|Oct 29, 2025
LC-MS/MS Method Development and Validation for Clinical Pharmacokinetics and Therapeutic Drug Monitoring of Potassium-Competitive Acid Blocker Vonoprazan-Based Triple Therapy for H. pylori in Human Plasma.

Naser F Al-Tannak, Hani M Hafez, Ahmed Hemdan

|Sep 13, 2025
Development and Validation of an LC-MS/MS Method for the Simultaneous Determination of Alprazolam, Bromazepam, Clonazepam, Diazepam and Flunitrazpam in Human Urine and Its Application to Samples from Suspected Drug Abusers.

Husein Kamal, Varun Gandhi, Lina Akil

Pageof 1

Frequent Collaborators

2 joint publications

Ibrahim Khadra

2 joint publications

Oludotun A Phillips

2 joint publications

Sylvester Nnaemeka Ugariogu

1 joint publications

Nicholas J W Rattray